IDEXX Laboratories (NASDAQ:IDXX) will release its quarterly earnings report on Monday, 2025-08-04. Here’s a brief overview for investors ahead of the announcement.
Analysts anticipate IDEXX Laboratories to report an earnings per share (EPS) of $3.30.
The announcement from IDEXX Laboratories is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It’s worth noting for new investors that guidance can be a key determinant of stock price movements.
Past Earnings Performance
The company’s EPS beat by $0.06 in the last quarter, leading to a 0.11% increase in the share price on the following day.
Here’s a look at IDEXX Laboratories’s past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | 2.85 | 2.40 | 2.68 | 2.87 |
| EPS Actual | 2.91 | 2.53 | 2.79 | 3.02 |
| Price Change % | 0.0% | -1.0% | 3.0% | -0.0% |
Stock Performance
Shares of IDEXX Laboratories were trading at $534.31 as of July 31. Over the last 52-week period, shares are up 17.0%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
Analyst Insights on IDEXX Laboratories
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on IDEXX Laboratories.
The consensus rating for IDEXX Laboratories is Outperform, based on 5 analyst ratings. With an average one-year price target of $557.6, there’s a potential 4.36% upside.